Hironori Goto

Dr. Hironori Goto


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2014 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
SKSeigo Korematsu
Seigo Korematsu
HGHironori Goto
Hironori Goto
CGChika Gotoh
Chika Gotoh
RORyoko Ohki
Ryoko Ohki
TKToshiaki Kubota
Toshiaki Kubota
TITatsuro Izumi
Tatsuro Izumi
Antiphospholipid antibody syndrome is characterized by venous and/or arterial thrombosis, and is found in patients with systemic lupus erythematosus. Its diagnosis requires the presence of both clinical and laboratory findings, such as positive anti-cardiolipin and anti-β2 glycoprotein I antibodies and lupus anticoagulant. However, cardiolipin is a minor component of the vascular endothelial cells in human, and phosphatidylcholine and phosphatidylethanolamine are major components.

15 December 2022 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
HGHironori Goto
Hironori Goto
YKYuhki Koga
Yuhki Koga
KKKenichi Kohashi
Kenichi Kohashi
HOHiroaki Ono
Hiroaki Ono
JTJunkichi Takemoto
Junkichi Takemoto
SOShouichi Ohga
Shouichi Ohga

17 September 2024 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
HGHironori Goto
Hironori Goto
UOUtako Oba
Utako Oba
TUTamaki Ueda
Tamaki Ueda
SYShunsuke Yamamoto
Shunsuke Yamamoto
MIMasataka Inoue
Masataka Inoue
SOShouichi Ohga
Shouichi Ohga
Background: Veno‐occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), is a life‐threatening complications of hematopoietic cell transplantation (HCT). Methods: We studied the impact of early defibrotide (DF) therapy on the outcomes of pediatric patients with VOD/SOS after transplantation, focusing on recent immunotherapies. A total of 111 pediatric patients who underwent HCT for malignant disease between February 2017 and March 2023 at Kyushu University Hospital were included. Results: Among 111 patients of less than 20 years of age who underwent HCT for malignancy at a single institution between 2017 and 2023, VOD/SOS occurred in 25 (23%) patients. VOD/SOS developed more frequently in the post‐DF era (2020–2023, n = 58) than in the pre‐DF era (31% vs. 13%, p  = .04). The proportion of patients with relapsed/refractory acute lymphoblastic leukemia (ALL) was higher in the post‐DF era than in the pre‐DF era (44% vs. 8%, p  = .04). Early DF therapy that was started at two European Society for Blood and Marrow Transplantation diagnostic criteria reduced the severity of VOD/SOS ( p  < .01) in comparison to non‐early therapy started at less than two criteria. A multivariate analysis indicated that a history of cytokine release syndrome (odds ratio [OR] = 10.4, p  = .01) and juvenile myelomonocytic leukemia (OR = 8.98, p  = .04), but not an endothelial activation and stress index (EASIX) score of greater than 0.85, were independent risk factors for VOD/SOS. Conclusions: Early DF therapy improves the severity and survival outcomes of post‐transplant VOD/SOS in children. However, its incidence is increasing in the era of immunotherapy for progressive diseases.

19 May 2017 in Hormone Research in Paediatrics
Verified
Journal Article
Closed access
PDF file
TITomoyo Itonaga
Tomoyo Itonaga
HGHironori Goto
Hironori Goto
MTManabu Toujigamori
Manabu Toujigamori
YOYasuharu Ohno
Yasuharu Ohno
SKSeigo Korematsu
Seigo Korematsu
KIKenji Ihara
Kenji Ihara
Background: Bilateral adrenalectomy is performed in cases with infantile-onset Cushing syndrome due to bilateral adrenal hyperplasia in McCune-Albright syndrome (MAS) because severe Cushing syndrome with heart failure and liver dysfunction can have a lethal outcome. This procedure can completely ameliorate hypercortisolism, although lifetime steroid replacement therapy and steps to prevent adrenal crisis are necessary. Recently, the efficacy of unilateral adrenalectomy has been reported in adult cases of bilateral macronodular adrenal hyperplasia, but there is no consensus regarding the appropriate surgical treatment for bilateral adrenal hyperplasia in MAS. Objective: A 6-month-old girl presented with café-au-lait spots, short stature, central obesity, a moon face, and hypertension. Endocrinological tests and imaging studies led to the diagnosis of ACTH-independent Cushing syndrome due to bilateral adrenal hyperplasia induced by MAS. “Three-quarters adrenalectomy”, namely right-sided total adrenalectomy and left-sided half adrenalectomy, was carried out. An activating mutation of the GNAS1 gene (p.Arg201Cys) was identified in the adrenal tissues. Since the operation, our patient has been in a state of clinical remission for more than 2 years. Conclusion: Our original surgical intervention, three-quarters adrenalectomy, may be a new treatment option for Cushing syndrome associated with MAS.

10 December 2019 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
SSSouichi Suenobu
Souichi Suenobu
HGHironori Goto
Hironori Goto
NHNaoki Hirano
Naoki Hirano
TSTomoko Sonoda
Tomoko Sonoda
TITatsuro Izumi
Tatsuro Izumi
KIKenji Ihara
Kenji Ihara
Purpose: There have been few reports on height disturbance in childhood acute lymphoblastic leukemia (ALL) patients treated without cranial radiation therapy (CRT). Our study aimed to clarify the critical period of growth in pediatric patients who were treated by the Japan Childhood Leukemia Study (JACLS) ALL-02 protocol, which involved short-term intensive treatment without CRT. Patients and Methods: A retrospective, cohort study was conducted for prepubertal children with B-precursor ALL who were diagnosed from July 2002 to November 2011 and treated by the JACLS ALL-02 protocol at Oita University Hospital. The heights were chronologically measured at pretreatment, after the intensive phase (INT), at the end of treatment (END), and at 1 to 5 year(s) posttreatment (POST 1 to 5). Results: Nine boys and 4 girls were enrolled. Z score of the height was reduced at INT and END. Delta Z scores of the height and Z score of height velocity were reduced from pretreatment to INT, and they demonstrated an early recovery during maintenance treatment in INT to END. Conclusions: Early recovery of delta Z scores of the height and Z score of height velocity was observed during the INT to END period. The shortened intensive phase without CRT may result in an adequate height in prepubertal ALL patients.

6 December 2019 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
HGHironori Goto
Hironori Goto
NHNaoki Hirano
Naoki Hirano
HKHiroko Kadowaki
Hiroko Kadowaki
SSSouichi Suenobu
Souichi Suenobu
KIKenji Ihara
Kenji Ihara